Salvage therapy with T-cell redirection enhances OS. (A) OS of the full cohort of 58 patients. (B) OS of 19 patients receiving T-cell redirection as the FST compared with 39 patients receiving all other types of treatments. (C) OS of 28 patients receiving T-cell redirection as FST or SST compared with 30 patients receiving all other types of treatments.